Biology professor Martha Grossel has been awarded a grant of $412,470 from the National Institutes of Health’s National Cancer Institute to continue cutting-edge cancer research.

Grossel’s research focuses on the unregulated cellular division that is associated with cancer  — particularly on the interaction of the cell cycle regulatory protein “Cyclin Dependent Kinase 6” (cdk6) and the developmentally important transcription factor “Eyes absent homolog 2” (Eya2).

Grossel’s team includes Connecticut College students and collaborators Philip Hinds, professor and chair of the Department of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine; Heide Ford, professor of pharmacology at the University of Colorado School of Medicine; and Dawn Kohrt, research associate at Connecticut College.